190 related articles for article (PubMed ID: 19958308)
1. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.
Hendriks GJ; Keijsers GP; Kampman M; Oude Voshaar RC; Verbraak MJ; Broekman TG; Hoogduin CA
Acta Psychiatr Scand; 2010 Jul; 122(1):11-9. PubMed ID: 19958308
[TBL] [Abstract][Full Text] [Related]
2. Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.
Hendriks GJ; Keijsers GP; Kampman M; Hoogduin CA; Oude Voshaar RC
Int J Geriatr Psychiatry; 2012 Feb; 27(2):146-50. PubMed ID: 21452176
[TBL] [Abstract][Full Text] [Related]
3. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
[TBL] [Abstract][Full Text] [Related]
5. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder.
Gulpers B; Oude Voshaar R; Kampman M; Verhey F; VAN Alphen S; Hendriks GJ
J Psychiatr Pract; 2020 May; 26(3):164-174. PubMed ID: 32421288
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
[TBL] [Abstract][Full Text] [Related]
8. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
Bakker A; van Balkom AJ; van Dyck R
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
13. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.
Sharp DM; Power KG; Simpson RJ; Swanson V; Anstee JA
Br J Gen Pract; 1997 Mar; 47(416):150-5. PubMed ID: 9167318
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
15. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
16. [The role of psychotherapy in managing panic disorder].
Cottraux J
Encephale; 1996 Dec; 22 Spec No 5():54-60. PubMed ID: 9138948
[TBL] [Abstract][Full Text] [Related]
17. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
[TBL] [Abstract][Full Text] [Related]
18. Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: a randomized controlled trial.
Meyerbroeker K; Morina N; Kerkhof GA; Emmelkamp PM
Psychother Psychosom; 2013; 82(3):170-6. PubMed ID: 23548832
[TBL] [Abstract][Full Text] [Related]
19. Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study.
Stein MB; Ron Norton G; Walker JR; Chartier MJ; Graham R
Psychiatry Res; 2000 Jul; 94(3):191-200. PubMed ID: 10889283
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder.
Wedekind D; Broocks A; Weiss N; Engel K; Neubert K; Bandelow B
World J Biol Psychiatry; 2010 Oct; 11(7):904-13. PubMed ID: 20602575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
